Treatment of microbial biofilms in the post-antibiotic era: Prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools

Pathogens and Disease

Volumn 70, Issue 3, 2014, Pages 257-270

  di Luca, Mariagrazia ^a   Maccari, Giuseppe ^b   Nifosí, Riccardo ^a  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

Author keywords

AMP modeling and design; Antibiotic resistance; Antimicrobial peptides; Biofilm simulations; Microbial biofilm; Surface coating

Indexed keywords

BETA DEFENSIN 3; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHELICIDIN DERIVATIVE; HISTATIN DERIVATIVE; LACTOFERRIN; POLYPEPTIDE ANTIBIOTIC AGENT; POLYSACCHARIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; BIOFILM; BIOINFORMATICS; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFECTION; INNATE IMMUNITY; MATHEMATICAL ANALYSIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SHORT SURVEY; BIOLOGY; CLASSIFICATION; DRUG EFFECTS; MICROFLORA; PROCEDURES;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; COMPUTATIONAL BIOLOGY; DRUG DESIGN; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIOTA;

EID: 84908200723     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1111/2049-632X.12151     Document Type: Short Survey

References (121)

1. Ammons MC & Copié V (2013) Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 29: 443-455.
2. Ammons MCB, Ward LS, Fisher ST, Wolcott RD & James GA (2009) In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents 33: 230-236.
3. Andreu D, Ubach J, Boman A, Wåhlin B, Wade D, Merrifield RB & Boman HG (1992) Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett 296: 190-194.
4. Bagheri M, Beyermann M & Dathe M (2009) Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob Agents Chemother 53: 1132-1141.
5. Bahar A & Ren D (2013) Antimicrobial peptides. Pharmaceuticals 6: 1543-1575.
6. Balaban N, Gov Y, Giacometti A, et al. (2004) A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob Agents Chemother 48: 2544-2550.
7. Batoni G, Maisetta G, Brancatisano FL, Esin S & Campa M (2011) Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem 18: 256-279.
8. Brancatisano FL, Maisetta G, Di Luca M, Esin S, Bottai D, Bizzarri R, Campa M & Batoni G (2014) Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIAnegative strains of Staphylococcus epidermidis. Biofouling doi:10.1080/08927014.2014.888062
9. Bryers JD (2008) Medical biofilms. Biotechnol Bioeng 100: 1-18.
10. Chan C, Burrows LL & Deber CM (2004) Helix induction in antimicrobial peptides by alginate in biofilms. J Biol Chem 279: 38749-38754.
11. Chen L & Gao L (2012) How the antimicrobial peptides kill bacteria: computational physics insights. Commun Comput Phys http:// www.global-sci.com/issue/abstract/readabs.php?vol=11&page= 709&issue=3&ppage=725&year=2012 (AccessedAugust 7, 2013).
12. Chennupati SK, Chiu AG, Tamashiro E, Banks CA, Cohen MB, Bleier BS, Kofonow JM, Tam E & Cohen NA (2009) Effects of an LL-37-derived antimicrobial peptide in an animal model of biofilm Pseudomonas sinusitis. Am J Rhinol Allergy 23: 46-51.
13. Chhibber S, Nag D & Bansal S (2013) Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage. BMC Microbiol 13: 174.
14. Cho W-M, Joshi BP, Cho H & Lee K-H (2007) Design and synthesis of novel antibacterial peptide-resin conjugates. Bioorg Med Chem Lett 17: 5772-5776.
15. Cirioni O, Giacometti A, Ghiselli R, Kamysz W et al. (2006a) Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides 27: 1210- 1216.
16. Cirioni O, Giacometti A, Ghiselli R, Bergnach C et al. (2006b) Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides 27: 2104-2110.
17. Coello CA, Lamont G & Van Veldhuizen D (2007) Evolutionary Algorithms for Solving Multi-Objective Problems SE - Genetic and Evolutionary Computation. Springer, New York, NY citeulike- article-id:2242111.
18. Coello CA, Lamont G & Van Veldhuizen D (2007) Evolutionary Algorithms for Solving Multi-Objective Problems SE - Genetic and Evolutionary Computation. Springer, New York, NY citeulike- article-id:2242111.
19. Costerton JW, Stewart PS & Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
20. Da Silva BR, de Freitas VAA, Carneiro VA, Arruda FVS, Lorenzón EN, de Aguiar ASW, Cilli EM, Cavada BS & Teixeira EH (2013) Antimicrobial activity of the synthetic peptide Lys-a1 against oral streptococci. Peptides 42: 78-83.
21. De la Fuente-Núñez C, Korolik V, Bains M, Nguyen U, Breidenstein EBM, Horsman S, Lewenza S, Burrows L & Hancock REW (2012) Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother 56: 2696-2704.
22. Dean SN, Bishop BM & van Hoek ML (2011) Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus. BMC Microbiol 11: 114.
23. Dittmer J, Thørgersen L, Underhaug J et al. (2009) Incorporation of antimicrobial peptides into membranes: a combined liquid-state NMR and molecular dynamics study of alamethicin in DMPC/ DHPC bicelles. J Phys Chem B 113: 6928-6937.
24. Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
25. Duperthuy M, Sjöström AE, Sabharwal D, Damghani F, Uhlin BE & Wai SN (2013) Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides. PLoS Pathog 9: e1003620.
26. Duplantier AJ & van Hoek ML (2013) The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds. Front Immunol 4: 143.
27. Eckert R, Brady KM, Greenberg EP, Qi F, Yarbrough DK, He J, McHardy I, Anderson MH & Shi W (2006a) Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrob Agents Chemother 50: 3833-3838.
28. Eckert R, He J, Yarbrough DK, Qi F, Anderson MH & Shi W (2006b) Targeted killing of Streptococcus mutans by a pheromone-guided "smart" antimicrobial peptide. Antimicrob Agents Chemother 50: 3651-3657.
29. Feng X, Sambanthamoorthy K, Palys T & Paranavitana C (2013) The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii. Peptides 49: 131- 137.
30. Fjell CD, Jenssen H, Cheung WA, Hancock REW & Cherkasov A (2011) Optimization of antibacterial peptides by genetic algorithms and cheminformatics. Chem Biol Drug Des 77: 48-56.
31. Fjell CD, Hiss JA, Hancock REW & Schneider G (2012) Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11: 37-51.
32. Flower DR, Macdonald IK, Ramakrishnan K, Davies MN & Doytchinova IA (2010) Computer aided selection of candidate vaccine antigens. Immunome Res 6(suppl 2): S1.
33. Friedrich C, Scott MG, Karunaratne N, Yan H & Hancock RE (1999) Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother 43: 1542-1548.
34. Friedrich CL, Rozek A, Patrzykat A & Hancock RE (2001) Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J Biol Chem 276: 24015-24022.
35. Gao G, Lange D, Hipert K et al. (2011) The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 32: 3899-3909.
36. Ghiselli R, Giacometti A, Cirioni O et al. (2007) Pretreatment with the protegrin IB-367 affects gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. J Parenter Enteral Nutr 31: 463-468.
37. Giugliano LG, Ribeiro ST, Vainstein MH & Ulhoa CJ (1995) Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J Med Microbiol 42: 3-9.
38. Gopal R, Lee JH, Kim YG, Kim M-S, Seo CH & Park Y (2013) Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus. Mar Drugs 11: 1836-1852.
39. Gurtovenko AA, Anwar J & Vattulainen I (2010) Defect-mediated trafficking across cell membranes: insights from in silico modeling. Chem Rev 110: 6077-6103.
40. Hall-Stoodley L, Stoodley P, Kathju S, Høiby N, Moser C, Costerton JW, Moter A & Bjarnsholt T (2012) Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 65: 127-145.
41. Hancock REW & Rozek A (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206: 143-149.
42. Hancock RE & Scott MG (2000) The role of antimicrobial peptides in animal defenses. P Natl Acad Sci USA 97: 8856-8861.
43. Harris F, Dennison SR & Phoenix DA (2009) Anionic antimicrobial peptides from eukaryotic organisms. Curr Protein Pept Sci 10: 585-606.
44. Haynie SL, Crum GA & Doele BA (1995) Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin. Antimicrob Agents Chemother 39: 301-307.
45. Hell E, Giske CG, Nelson A, Römling U & Marchini G (2010) Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 50: 211-215.
46. Helmerhorst EJ, Hodgson R, van't Hof W, Veerman EC, Allison C & Nieuw Amerongen AV (1999) The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res 78: 1245-1250.
47. Hetrick EM & Schoenfisch MH (2006) Reducing implant-related infections: active release strategies. Chem Soc Rev 35: 780-789.
48. Hilpert K et al. (2009) Screening and characterization of surface- tethered cationic peptides for antimicrobial activity. Chem Biol 16: 58-69.
49. Høiby N, Bjarnsholt T, Givskov M, Molin S & Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35: 322-332.
50. Huang Q, Yu HJ, Liu GD et al. (2012) Comparison of the effects of human b-defensin 3, vancomycin, and clindamycin on Staphylococcus aureus biofilm formation. Orthopedics 35: e53-e60.
51. Huh AJ & Kwon YJ (2011) "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156: 128-145.
52. Jacobsen AS & JenssenH(2012) Human cathelicidin LL-37 prevents bacterial biofilm formation. Future Med Chem 4: 1587-1599.
53. Jean-François F, Elezgaray J, Berson P, Vacher P & Dufourc EJ (2008) Pore formation induced by an antimicrobial peptide: electrostatic effects. Biophys J 95: 5748-5756.
54. Jin Y, Hammer J, Pate M, Zhang Y, Zhu F, Zmuda E & Blazyk J (2005) Antimicrobial activities and structures of two linear cationic peptide families with various amphipathic beta-sheet and alpha-helical potentials. Antimicrob Agents Chemother 49: 4957-4964.
55. Jones EA, McGillivary G & Bakaletz LO (2013) Extracellular DNA within a nontypeable Haemophilus influenzae-induced biofilm binds human beta defensin-3 and reduces its antimicrobial activity. J Innate Immun 5: 24-38.
56. Jorge P, Lourenço A & Pereira MO (2012) New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches. Biofouling 28: 1033-1061.
57. Kandasamy SK & Larson RG (2004) Binding and insertion of alpha-helical anti-microbial peptides in POPC bilayers studied by molecular dynamics simulations. Chem Phys Lipids 132: 113- 132.
58. Kanthawong S, Bolscher JGM, Veerman ECI, van Marle J, de Soet HJJ, Nazmi K, Wongratanacheewin S & Taweechaisupapong S (2012) Antimicrobial and antibiofilm activity of LL-37 and its truncated variants against Burkholderia pseudomallei. Int J Antimicrob Agents 39: 39-44.
59. Kapellos GE, Alexiou TS & Payatakes AC (2010) Theoretical modeling of fluid flow in cellular biological media: an overview. Math Biosci 225: 83-93.
60. Kazemzadeh-Narbat M, Lai BFL, Ding C, Kizhakkedathu JN, Hancock REW & Wang R (2013) Multilayered coating on titanium for controlled release of antimicrobial peptides for the prevention of implant-associated infections. Biomaterials 34: 5969-5977.
61. Kocianova S, Vuong C, Yao Y, Voyich JM, Fischer ER, DeLeo FR & Otto M (2005) Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest 115: 688-694.
62. Kraus D & Peschel A (2006) Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr Top Microbiol Immunol 306: 231-250.
63. Lapins M & Wikberg JE (2010) Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques. BMC Bioinformatics 11: 339.
64. Leach A (2001) Molecular Modelling: Principles and Applications, 2nd edn. Pearson Education Limited, Harlow, UK, pp165-247, 353-406.
65. Lee J-K et al. (2013) Antibacterial efficacy of a human b-defensin-3 peptide on multispecies biofilms. J Endod 39: 1625-1629.
66. Li L, He J, Eckert R, Yarbrough D, Lux R, Anderson M & Shi W (2010) Design and characterization of an acid-activated antimicrobial peptide. Chem Biol Drug Des 75: 127-132.
67. Lim K, Chua RRY, Saravanan R, Basu A, Mishra B, Tambyah PA, Ho B & Leong SSJ (2013) Immobilization studies of an engineered arginine-tryptophan-rich peptide on a silicone surface with antimicrobial and antibiofilm activity. ACS Appl Mater Interfaces 5: 6412-6422.
68. Loose C, Jensen K, Rigoutsos I & Stephanopoulos G (2006) A linguistic model for the rational design of antimicrobial peptides. Nature 443: 867-869.
69. Maccari G, Di Luca M, Nifosí R, Cardarelli F, Signore G, Boccardi C & Bifone A (2013) Antimicrobial peptides design by evolutionary multiobjective optimization. PLoS Comput Biol 9: e1003212.
70. Mah T-F (2012) Biofilm-specific antibiotic resistance. Future Microbiol 7: 1061-1072.
71. Mah TF & O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
72. Maisetta G, Batoni G, Esin S, Florio W, Bottai D, Favilli F & Campa M (2006) In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob Agents Chemother 50: 806-809.
73. Maisetta G, Di Luca M, Esin S, Florio W, Brancatisano FL, Bottai D, Campa M & Batoni G (2008) Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29: 1-6.
74. Maisetta G, Mangoni ML, Esin S et al. (2009) In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin- 1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia. Peptides 30: 1622-1626.
75. Mataraci E & Dosler S (2012) In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother 56: 6366-6371.
76. Matl FD, Obermeier A, Repmann S, Friess W, Stemberger A & Kuehn K-D (2008) New anti-infective coatings of medical implants. Antimicrob Agents Chemother 52: 1957-1963.
77. Matyus E, Kandt C & Tieleman D (2007) Computer simulation of antimicrobial peptides. Curr Med Chem 14: 2789-2798.
78. Menousek J, Mishra B, Hanke ML, Heim CE, Kielian T & Wang G (2012) Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300. Int J Antimicrob Agents 39: 402-406.
79. Minardi D, Ghiselli R, Cirioni O et al. (2007) The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model. Peptides 28: 2293-2298.
80. Molhoek EM, van Dijk A, Veldhuizen EJA, Haagsman HP & Bikker FJ (2011) A cathelicidin-2-derived peptide effectively impairs Staphylococcus epidermidis biofilms. Int J Antimicrob Agents 37: 476-479.
81. Nagant C, Pitts B, Nazmi K, Vandenbranden M, Bolscher JG, Stewart PS & Dehaye J-P (2012) Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrob Agents Chemother 56: 5698-5708.
82. Novković M, Simunić J, Bojović V, Tossi A & Juretić D (2012) DADP: the database of anuran defense peptides. Bioinformatics 28: 1406-1407.
83. Otto M (2006) Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol 306: 251-258.
84. Overhage J, Campisano A, Bains M, Torfs ECW, Rehm BHA & Hancock REW (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76: 4176- 4182.
85. Park Y & Hahm K-S (2005) Antimicrobial peptides (AMPs): peptide structure and mode of action. J Biochem Mol Biol 38: 507-516.
86. Park CB, Kim HS & Kim SC (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244: 253-257.
87. Park S-C, Park Y & Hahm K-S (2011) The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci 12: 5971-5992.
88. Parton DL, Akhmatskaya EV & Sansom MSP (2012) Multiscale simulations of the antimicrobial peptide maculatin 1.1: water permeation through disordered aggregates. J Phys Chem B 116: 8485-8493.
89. Paulmann M et al. (2012) Structure-activity analysis of the dermcidin- derived peptide DCD-1L, an anionic antimicrobial peptide present in human sweat. J Biol Chem 287: 8434-8443.
90. Peter Tieleman D, Hess B & Sansom MSP (2002) Analysis and evaluation of channel models: simulations of alamethicin. Biophys J 83: 2393-2407.
91. Pissurlenkar RRS, Malde AK, Khedkar SA & Coutinho EC (2007) Encoding type and position in peptide QSAR: application to peptides binding to class I MHC molecule HLA-A*0201. QSAR Comb Sci 26: 189-203.
92. Pompilio A, Scocchi M, Pomponio S, Guida F, Di Primio A, Fiscarelli E, Gennaro R & Di Bonaventura G (2011) Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. Peptides 32: 1807-1814.
93. Pusateri CR, Monaco EA & Edgerton M (2009) Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine. Arch Oral Biol 54: 588-594.
94. Römling U & Balsalobre C (2012) Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 272: 541-561.
95. Salomone F, Cardarelli F, Di Luca M, Boccardi C, Nifosí R, Bardi G, Di Bari L, Serresi M & Beltram F (2012) A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J Control Release 163: 293- 303.
96. Sengupta D, Leontiadou H, Mark AE & Marrink S-J (2008) Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim Biophys Acta 1778: 2308-2317.
97. Shai Y & Oren Z (2001) From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22: 1629-1641.
98. Shirtliff ME, Peters BM & Jabra-Rizk MA (2009) Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 299: 1-8.
99. Singh PK, Parsek MR, Greenberg EP & Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555.
100. Sobczak M, Dezbek C, Olezdzka E & Kozlowski R (2013) Polymeric systems of antimicrobial peptides-strategies and potential applications. Molecules 18: 14122-14137.
101. Tati S, Li R, Puri S, Kumar R, Davidow P & Edgerton M (2013) Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis. Antimicrob Agents Chemother http://www.ncbi.nlm.nih.gov/pubmed/ 24247141 (Accessed December 11, 2013).
102. Theberge S, Semlali A, Alamri A, Leung KP & Rouabhia M (2013) C. albicans growth, transition, biofilm formation, and gene expression modulation by antimicrobial decapeptide KSL-W. BMC Microbiol 13: 246.
103. Thomas S, Karnik S, Barai RS, Jayaraman VK & Idicula-Thomas S (2010) CAMP: a useful resource for research on antimicrobial peptides. Nucleic Acids Res 38: D774-D780.
104. Tsai C-W, Hsu N-Y, Wang C-H, Lu C-Y, Chang Y, Tsai H-HG & Ruaan R-C (2009) Coupling molecular dynamics simulations with experiments for the rational design of indolicidin-analogous antimicrobial peptides. J Mol Biol 392: 837-854.
105. Turner J, Cho Y, Dinh NN, Waring AJ & Lehrer RI (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42: 2206-2214.
106. Urban P, Jose Valle-Delgado J, Moles E, Marques J, Diez C & Fernandez-Busquets X (2012) Nanotools for the delivery of antimicrobial peptides. Curr Drug Targets 13: 1158-1172.
107. Uyterhoeven ET, Butler CH, Ko D & Elmore DE (2008) Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II. FEBS Lett 582: 1715-1718.
108. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR & Otto M (2004) Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6: 269- 275.
109. Wang P, Hu L, Liu G et al. (2011) Prediction of antimicrobial peptides based on sequence alignment and feature selection methods. PLoS One 6: e18476.
110. Wei G-X, Campagna AN & Bobek LA (2006) Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57: 1100-1109.
111. Weinberg ED (2004) Suppression of bacterial biofilm formation by iron limitation. Med Hypotheses 63: 863-865.
112. Wenzel RP (2007) Health care-associated infections: major issues in the early years of the 21st century. Clin Infect Dis 45(suppl 1): S85-S88.
113. Whittaker CJ, Klier CM & Kolenbrander PE (1996) Mechanisms of adhesion by oral bacteria. Annu Rev Microbiol 50: 513-552.
114. Wolcott R, Costerton JW, Raoult D & Cutler SJ (2013) The polymicrobial nature of biofilm infection. Clin Microbiol Infect 19: 107-112.
115. Wold S, Jonsson J, Sjörström M, Sandberg M & Rännar S (1993) DNA and peptide sequences and chemical processes multivariately modelled by principal component analysis and partial least-squares projections to latent structures. Anal Chim Acta 277: 239-253.
116. Yang L, Liu Y, Wu H, Hóiby N, Molin S & Song Z (2011) Current understanding of multi-species biofilms. Int J Oral Sci 3: 74-81.
117. Yoshinari M, Kato T, Matsuzaka K, Hayakawa T & Shiba K (2010) Prevention of biofilm formation on titanium surfaces modified with conjugated molecules comprised of antimicrobial and titanium- binding peptides. Biofouling 26: 103-110.
118. Yu H-Y, Tu C-H, Yip B-S, Chen H-L, Cheng H-T, Huang K-C, Lo H-J & Cheng J-W (2011) Easy strategy to increase salt resistance of antimicrobial peptides. Antimicrob Agents Chemother 55: 4918- 4921.
119. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
120. Zhang L, Pornpattananangku D, Hu C-MJ & Huang C-M (2010) Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17: 585-594.
121. Zhu C, Tan H, Cheng T, Shen H, Shao J, Guo Y, Shi S & Zhang X (2013a) Human b-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J Surg Res 183: 204-213.
122. Zhu Y, Dashper SG, Chen Y-Y, Crawford S, Slakeski N & Reynolds EC (2013b) Porphyromonas gingivalis and Treponema denticola synergistic polymicrobial biofilm development. PLoS One 8: e71727.